Microglial Lectins in Health and Neurological Diseases

by Jian Jing Siew, Jian Jing Siew, Yijuang Chern, Yijuang Chern
Published 2018-05-01

Contribution of Energy Dysfunction to Impaired Protein Translation in Neurodegenerative Diseases

by Yu-Ju Liu, Yijuang Chern
Published 2021-07-01

Insights into GABAAergic system alteration in Huntington's disease

by Yi-Ting Hsu, Ya-Gin Chang, Yijuang Chern
Published 2018-12-01

Energy Homeostasis and Abnormal RNA Metabolism in Amyotrophic Lateral Sclerosis

by Yu-Ju Liu, Po-Yi Tsai, Yijuang Chern
Published 2017-05-01

PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease

by Ming-Chang Chiang, Yijuang Chern, Rong-Nan Huang
Published 2012-01-01

The TRAX, DISC1, and GSK3 complex in mental disorders and therapeutic interventions

by Yu-Ting Weng, Ting Chien, I-I Kuan, Yijuang Chern
Published 2018-10-01

The D2 Dopamine Receptor Interferes With the Protective Effect of the A2A Adenosine Receptor on TDP-43 Mislocalization in Experimental Models of Motor Neuron Degeneration

by Chia-You Lai, Chia-You Lai, Yu-Ju Liu, Hsing-Lin Lai, Hui-Mei Chen, Hung-Chi Kuo, Yu-Ping Liao, Yijuang Chern, Yijuang Chern
Published 2018-03-01

The adenosine A2A receptor agonist T1–11 ameliorates neurovisceral symptoms and extends the lifespan of a mouse model of Niemann-Pick type C disease

by Antonella Ferrante, Antonella Pezzola, Andrea Matteucci, Antonella Di Biase, Lucilla Attorri, Monica Armida, Alberto Martire, Yijuang Chern, Patrizia Popoli
Published 2018-02-01

Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models.

by Yuan-Ta Lin, Yijuang Chern, Che-Kun James Shen, Hsin-Lan Wen, Ya-Chin Chang, Hung Li, Tzu-Hao Cheng, Hsiu Mei Hsieh-Li
Published 2011-01-01

Adenosine A(2A) receptor up-regulates retinal wave frequency via starburst amacrine cells in the developing rat retina.

by Pin-Chien Huang, Yu-Tien Hsiao, Shao-Yen Kao, Ching-Feng Chen, Yu-Chieh Chen, Chung-Wei Chiang, Chien-Fei Lee, Juu-Chin Lu, Yijuang Chern, Chih-Tien Wang
Published 2014-01-01

The type VI adenylyl cyclase protects cardiomyocytes from β-adrenergic stress by a PKA/STAT3-dependent pathway

by Yu-Shuo Wu, Chien-Chang Chen, Chen-Li Chien, Hsing-Lin Lai, Si-Tse Jiang, Yong-Cyuan Chen, Lin-Ping Lai, Wei-Fan Hsiao, Wen-Pin Chen, Yijuang Chern
Published 2017-09-01

The influence of pathological mutations and proline substitutions in TDP-43 glycine-rich peptides on its amyloid properties and cellular toxicity.

by Chia-Sui Sun, Cindy Yu-Hsiang Wang, Bryan Po-Wen Chen, Ruei-Yu He, Gerard Chun-Hao Liu, Chih-Hsien Wang, Wenlung Chen, Yijuang Chern, Joseph Jen-Tse Huang
Published 2014-01-01

Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington disease

by Xavier Guitart, Jordi Bonaventura, William Rea, Marco Orrú, Lucrezia Cellai, Ilaria Dettori, Felicita Pedata, Marc Brugarolas, Antonio Cortés, Vicent Casadó, Ching-Pang Chang, Manikandan Narayanan, Yijuang Chern, Sergi Ferré
Published 2016-12-01

High Protein Diet and Huntington's Disease.

by Chiung-Mei Chen, Yow-Sien Lin, Yih-Ru Wu, Pei Chen, Fuu-Jen Tsai, Chueh-Lien Yang, Ya-Tzu Tsao, Wen Chang, I-Shan Hsieh, Yijuang Chern, Bing-Wen Soong
Published 2015-01-01

Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington’s disease

by Jian Jing Siew, Hui-Mei Chen, Huan-Yuan Chen, Hung-Lin Chen, Chiung-Mei Chen, Bing-Wen Soong, Yih-Ru Wu, Ching-Pang Chang, Yi-Chen Chan, Chun-Hung Lin, Fu-Tong Liu, Yijuang Chern
Published 2019-08-01

Effects on murine behavior and lifespan of selectively decreasing expression of mutant huntingtin allele by supt4h knockdown.

by Hui-Min Cheng, Yijuang Chern, I-Hui Chen, Chia-Rung Liu, Sih-Huei Li, Seung J Chun, Frank Rigo, C Frank Bennett, Ning Deng, Yanan Feng, Chyuan-Sheng Lin, Yu-Ting Yan, Stanley N Cohen, Tzu-Hao Cheng
Published 2015-03-01

Longitudinal evaluation of an N-ethyl-N-nitrosourea-created murine model with normal pressure hydrocephalus.

by Ming-Jen Lee, Ching-Pang Chang, Yi-Hsin Lee, Yi-Chih Wu, Hsu-Wen Tseng, Yu-Ying Tung, Min-Tzu Wu, Yen-Hui Chen, Lu-Ting Kuo, Dennis Stephenson, Shuen-Iu Hung, Jer-Yuarn Wu, Chen Chang, Yuan-Tsong Chen, Yijuang Chern
Published 2009-11-01

Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathy

by Ching-Pang Chang, Ya-Gin Chang, Pei-Yun Chuang, Thi Ngoc Anh Nguyen, Kuo-Chen Wu, Fang-Yi Chou, Sin-Jhong Cheng, Hui-Mei Chen, Lee-Way Jin, Kevin Carvalho, Vincent Huin, Luc Buée, Yung-Feng Liao, Chun-Jung Lin, David Blum, Yijuang Chern
Published 2021-06-01

Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease

by Emilie Faivre, Joana E. Coelho, Katja Zornbach, Enas Malik, Younis Baqi, Younis Baqi, Marion Schneider, Lucrezia Cellai, Kevin Carvalho, Shéhérazade Sebda, Martin Figeac, Sabiha Eddarkaoui, Raphaëlle Caillierez, Yijuang Chern, Michael Heneka, Michael Heneka, Nicolas Sergeant, Christa E. Müller, Annett Halle, Annett Halle, Luc Buée, Luisa V. Lopes, David Blum
Published 2018-07-01

A new drug design targeting the adenosinergic system for Huntington's disease.

by Nai-Kuei Huang, Jung-Hsin Lin, Jiun-Tsai Lin, Chia-I Lin, Eric Minwei Liu, Chun-Jung Lin, Wan-Ping Chen, Yuh-Chiang Shen, Hui-Mei Chen, Jhih-Bin Chen, Hsing-Lin Lai, Chieh-Wen Yang, Ming-Chang Chiang, Yu-Shuo Wu, Chen Chang, Jiang-Fan Chen, Jim-Min Fang, Yun-Lian Lin, Yijuang Chern
Published 2011-01-01